Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients.

MLA

Van Wigcheren, Glenn F., et al. “Cisplatin Inhibits Frequency and Suppressive Activity of Monocytic Myeloid-Derived Suppressor Cells in Cancer Patients.” Oncoimmunology, vol. 10, no. 1, June 2021, p. 1935557. EBSCOhost, https://doi.org/10.1080/2162402X.2021.1935557.

APA

Van Wigcheren, G. F., De Haas, N., Mulder, T. A., Horrevorts, S. K., Bloemendal, M., Hins-Debree, S., Mao, Y., Kiessling, R., van Herpen, C. M. L., Flórez-Grau, G., Hato, S. V., & De Vries, I. J. M. (2021). Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients. Oncoimmunology, 10(1), 1935557. https://doi.org/10.1080/2162402X.2021.1935557

Chicago

Van Wigcheren, Glenn F, Nienke De Haas, Tom A Mulder, Sophie K Horrevorts, Martine Bloemendal, Simone Hins-Debree, Yumeng Mao, et al. 2021. “Cisplatin Inhibits Frequency and Suppressive Activity of Monocytic Myeloid-Derived Suppressor Cells in Cancer Patients.” Oncoimmunology 10 (1): 1935557. doi:10.1080/2162402X.2021.1935557.